CN105866431A - 用于鉴定脂肪间充质干细胞的试剂盒 - Google Patents
用于鉴定脂肪间充质干细胞的试剂盒 Download PDFInfo
- Publication number
- CN105866431A CN105866431A CN201610312843.4A CN201610312843A CN105866431A CN 105866431 A CN105866431 A CN 105866431A CN 201610312843 A CN201610312843 A CN 201610312843A CN 105866431 A CN105866431 A CN 105866431A
- Authority
- CN
- China
- Prior art keywords
- induction
- detectable
- culture medium
- differentiation
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides, bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/998—Proteins not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N2502/1352—Mesenchymal stem cells
- C12N2502/1382—Adipose-derived stem cells [ADSC], adipose stromal stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种用于鉴定脂肪间充质干细胞的试剂盒,包括流式表型检测试剂套装、细胞固定液、普通培养基、成脂分化诱导及检测试剂套装、成骨分化诱导及检测试剂套装、成软骨分化诱导及检测试剂套装。传统成骨、成脂诱导分化通常需要大约24天,时间较长且诱导效率较低,本发明将成骨、成脂诱导分化时间缩短至18天,本发明提高诱导分化效率,缩短诱导分化的时间;同时传统流式检测大多只针对间充质干细胞通用的表面标志,而脂肪间充质干细胞具有不同于其他来源间充质干细胞的阳性表达的表面标志CD49d和阴性表达的CD106,本发明试剂盒中增加了CD49d抗体和CD106抗体,从而得出更为准确的鉴定结果。
Description
技术领域
本发明涉及一种试剂盒,尤其是一种用于鉴定脂肪间充质干细胞的试剂盒。
背景技术
目前越来越多的研究将脂肪分离间充质干细胞用于临床,脂肪间充质干细胞的发展前景也越来越好。国际细胞治疗协会(ISCT)规定间充质干细胞的鉴定包括形态学、流式表型和诱导分化能力三个方面。传统的间充质干细胞鉴定方法已经比较成熟,但是诱导分化过程中耗时较长,而且诱导效率较低,影响最终细胞鉴定结果。
发明内容
本发明所要解决的技术问题是,提供一种提高诱导分化效率,缩短诱导分化时间的用于鉴定脂肪间充质干细胞的试剂盒。
为了解决上述技术问题,本发明采用的技术方案是:一种用于鉴定脂肪间充质干细胞的试剂盒,包括流式表型检测试剂套装、细胞固定液、普通培养基、成脂分化诱导及检测试剂套装、成骨分化诱导及检测试剂套装、成软骨分化诱导及检测试剂套装;
所述流式表型检测试剂套装:包括CD73抗体、CD90抗体、CD105抗体、CD34抗体、CD45抗体、CD49d抗体、CD106抗体、IgG1抗体,每只均为200uL;
所述成脂分化诱导及检测试剂套装:包括100mL成脂诱导培养基和10mL成脂分化检测试剂,成脂诱导培养基为含有0.2-2mmoL/L谷氨酰胺、1-20μg/mL IGF-2、2-5mmol/L 3-磷酸甘油、0.25-1mmoL/L倍氯米松、0.1-0.5mmoL/L异丁基甲基黄嘌呤、100-200μmoL/L吲哚美辛、1-50μmoL/L乙酰CoA、体积分数2-10%胎牛血清的AMEM培养基;
所述成骨分化诱导及检测试剂套装:包括100mL成骨诱导培养基和10mL成骨分化检测试剂,成骨诱导培养基为含有0.5-2mmoL/L谷氨酰胺、0.5-2mmoL/L倍氯米松、5-20μg/mL TGF-β、2-10mmol/Lβ-甘油磷酸钠、15-25mmol/L维生素D3、20-30mmol/L维生素C、体积分数2-10%胎牛血的AMEM培养基;
所述成软骨分化诱导及检测试剂套装:包括100mL成软骨诱导培养基和10mL成软骨分化检测试剂,成软骨诱导培养基为含有5-10ng/ml TGF-β1、20-50mg/L维生素C、10-20nmol/L倍他米松、50-100mg/ml ITS、10-60mmol/L氨基葡萄糖、1-20mmol/L丙酮酸钠、2-10ug/mg亚油酸、1-8ng/ml人血清白蛋白、10-20mmol/Lβ-甘油磷酸钠、体积分数2-10%胎牛血清的AMEM培养基。
所述细胞固定液为20mL质量百分比浓度4%多聚甲醛的水溶液。
所述普通培养基为20mL含体积分数2-8%胎牛血清的AMEM培养基。
所述成脂分化检测试剂为含有1g/L茜素磺酸钠水溶液。
所述成骨分化检测试剂为含有质量体积分数为0.5%油红O的异丙醇溶液。
所述成软骨分化检测试剂为含有10g/L阿尔新兰、质量体积分数3%醋酸的水溶液。
本发明的有益效果是:提高诱导分化效率,缩短诱导分化的时间,传统成骨、成脂诱导分化通常需要大约24天,时间较长且诱导效率较低,本发明将成骨、成脂诱导分化时间缩短至18天;同时传统流式检测大多只针对间充质干细胞通用的表面标志,而脂肪间充质干细胞具有不同于其他来源间充质干细胞的阳性表达的表面标志CD49d和阴性表达的CD106,本发明试剂盒中增加了CD49d抗体和CD106抗体,从而得出更为准确的鉴定结果。
附图说明
图1流式检测结果图。
图2成脂分化染色图。
图3成骨分化染色图。
图4成软骨分化染色图。
具体实施方式
下面结合具体实施方式对本发明作进一步详细说明:
本发明的用于鉴定脂肪间充质干细胞的试剂盒,包括流式表型检测试剂套装、细胞固定液、普通培养基、成脂分化诱导及检测试剂套装、成骨分化诱导及检测试剂套装、成软骨分化诱导及检测试剂套装;
所述流式表型检测试剂套装:包括CD73抗体、CD90抗体、CD105抗体、CD34抗体、CD45抗体、CD49d抗体、CD106抗体、IgG1抗体,每只均为200uL;
所述成脂分化诱导及检测试剂套装:包括100mL成脂诱导培养基和10mL成脂分化检测试剂,成脂诱导培养基为含有0.2-2mmoL/L谷氨酰胺、1-20μg/mL IGF-2、2-5mmol/L 3-磷酸甘油、0.25-1mmoL/L倍氯米松、0.1-0.5mmoL/L异丁基甲基黄嘌呤、100-200μmoL/L吲哚美辛、1-50μmoL/L乙酰CoA、体积分数2-10%胎牛血清的AMEM培养基;
所述成骨分化诱导及检测试剂套装:包括100mL成骨诱导培养基和10mL成骨分化检测试剂,成骨诱导培养基为含有0.5-2mmoL/L谷氨酰胺、0.5-2mmoL/L倍氯米松、5-20μg/mL TGF-β、2-10mmol/Lβ-甘油磷酸钠、15-25mmol/L维生素D3、20-30mmol/L维生素C、体积分数2-10%胎牛血的AMEM培养基;
所述成软骨分化诱导及检测试剂套装:包括100mL成软骨诱导培养基和10mL成软骨分化检测试剂,成软骨诱导培养基为含有5-10ng/ml TGF-β1、20-50mg/L维生素C、10-20nmol/L倍他米松、50-100mg/ml ITS、10-60mmol/L氨基葡萄糖、1-20mmol/L丙酮酸钠、2-10ug/mg亚油酸、1-8ng/ml人血清白蛋白、10-20mmol/Lβ-甘油磷酸钠、体积分数2-10%胎牛血清的AMEM培养基。
所述细胞固定液为20mL质量百分比浓度4%多聚甲醛的水溶液。
所述普通培养基为20mL含体积分数2-8%胎牛血清的AMEM培养基。
所述成脂分化检测试剂为含有1g/L茜素磺酸钠水溶液。
所述成骨分化检测试剂为含有质量体积分数为0.5%油红O的异丙醇溶液。
所述成软骨分化检测试剂为含有10g/L阿尔新兰、质量体积分数3%醋酸的水溶液。
本发明的试剂盒操作步骤如下:
(1)流式检测步骤:
步骤一:将细胞悬液按照每管1×105数量分装到EP管内,离心后加入1mL PBS重悬后离心;
步骤二:加入相应的流式抗体,室温避光孵育30min;
步骤三:每管加入1mL PBS重悬后离心;
步骤四:每管加入1mL PBS重悬后流式细胞仪检测。
(2)成脂分化诱导及检测步骤:
步骤一:准备6孔培养板,将P4细胞按照2×103个/平方厘米的规格接种于普通培养液中;
步骤二:待细胞融合度长至70-80%,更换成脂诱导培养基培养,每三天换液一次。
步骤三:18天后去除全部培养液,使用PBS清洗两次。
步骤四:4%多聚甲醛室温固定20分钟;PBS清洗3次;
步骤五:按照1ml/孔加入成脂分化检测试剂,室温孵育一小时;
步骤六:清除掉没有完全结合的染料,75%乙醇溶液清洗3次;
步骤七:倒置显微镜观察拍照记录。
(3)成骨分化诱导及检测步骤:
步骤一:准备6孔培养板,将P4细胞按照5×103个/平方厘米的规格接种于普通培养液中;
步骤二:待细胞融合度长至40-50%,更换成骨诱导培养基;每三天换液一次;
步骤三:18天后去除全部培养液,使用PBS清洗两次;
步骤四:使用4%多聚甲醛室温固定15min,完成后使用PBS冲洗两次;
步骤五:按照1ml/孔加入成骨分化检测试剂,室温孵育20min并轻微振荡;
步骤六:清除掉没有完全结合的染料,用PBS漂洗并振荡5min重复4次;
步骤七:倒置显微镜观察拍照记录。
(4)成软骨分化诱导及检测步骤:
步骤一:准备6孔培养板,将P4细胞按照5×103个/平方厘米的规格接种于普通培养液中;
步骤二:待细胞融合度长至50-60%,更换成软骨诱导培养基;每三天换液一次;
步骤三:13天后去除全部培养液,使用PBS清洗两次;
步骤四:用细胞固定液固定30min,再用3%醋酸水溶液洗2次后;(醋酸水溶液用户自己准备)
步骤五:按照1ml/孔加入成软骨分化检测试剂染色10~30min;
步骤六:清除掉没有完全结合的染料,3%醋酸水溶液洗3次;
步骤七:倒置显微镜观察拍照记录。
实施例1
所述成脂诱导分化试剂套装:包括100mL成脂诱导培养基和10mL成脂分化检测试剂,成脂诱导培养基为含有2mmoL/L谷氨酰胺、20μg/mL IGF-2、5mmol/L 3-磷酸甘油、1mmoL/L倍氯米松、0.5mmoL/L异丁基甲基黄嘌呤、200μmoL/L吲哚美辛、50μmoL/L乙酰CoA、体积分数10%胎牛血清的AMEM培养基;
所述成骨分化诱导及检测试剂套装:包括100mL成骨诱导培养基和10mL成骨分化检测试剂,成骨诱导培养基为含有2mmoL/L谷氨酰胺、2mmoL/L倍氯米松、20μg/mL TGF-β、10mmol/Lβ-甘油磷酸钠、25mmol/L维生素D3、30mmol/L维生素C、体积分数10%胎牛血的AMEM培养基;
所述成软骨分化诱导及检测试剂套装:包括100mL成软骨诱导培养基和10mL成软骨分化检测试剂,软骨诱导培养基为含有10ng/ml TGF-β1、50mg/L维生素C、20nmol/L倍他米松、100mg/ml ITS、60mmol/L氨基葡萄糖、20mmol/L丙酮酸钠、10ug/mg亚油酸、8ng/ml人血清白蛋白、20mmol/Lβ-甘油磷酸钠、体积分数10%胎牛血清的AMEM培养基。
(1)流式检测:
将细胞悬液按照每管1×105数量分装到EP管内,离心后加入1mL PBS重悬后离心;
加入相应的流式抗体,室温避光孵育30min;
每管加入1mL PBS重悬后离心;
每管加入1mL PBS重悬后流式细胞仪检测。IgG1为同型对照,检测结果CD73、CD90、CD105、CD49d为阳性表达,CD34、CD45、CD106为阴性表达,见图1。
(2)成脂分化诱导及检测:
准备6孔培养板,将P4细胞按照2×103个/平方厘米的规格接种于普通培养液中;
待细胞融合度长至80%,更换成脂诱导培养基培养,每三天换液一次。
18天后去除全部培养液,使用PBS清洗两次。
4%多聚甲醛室温固定20分钟;PBS清洗3次;
按照1ml/孔加入成脂分化检测试剂,室温孵育一小时;
清除掉没有完全结合的染料,75%乙醇溶液清洗3次;
倒置显微镜观察拍照记录。检测结果出现红色液滴,见图2。
(3)成骨分化诱导及检测:
准备6孔培养板,将P4细胞按照5×103个/平方厘米的规格接种于普通培养液中;
待细胞融合度长至40-50%,更换成骨诱导培养基;每三天换液一次;
18天后去除全部培养液,使用PBS清洗两次;
使用4%多聚甲醛室温固定15min,完成后使用PBS冲洗两次;
按照1ml/孔加入成骨分化检测试剂,室温孵育20min并轻微振荡;
清除掉没有完全结合的染料,用PBS漂洗并振荡5min重复4次;
倒置显微镜观察拍照记录。检测结果出现红色结节,见图3。
(4)成软骨分化诱导及检测:
准备6孔培养板,将P4细胞按照5×103个/平方厘米的规格接种于普通培养液中;
待细胞融合度长至60%,更换成软骨诱导培养基;每三天换液一次;
13天后去除全部培养液,使用PBS清洗两次;
用细胞固定液固定30min,再用3%醋酸水溶液洗2次后;按照1ml/孔加入成软骨分化检测试剂染色30min;
清除掉没有完全结合的染料,3%醋酸水溶液洗3次;
倒置显微镜观察拍照记录。检测结果出现蓝色,见图4。
实施例2
所述成脂诱导分化试剂套装:包括100mL成脂诱导培养基和10mL成脂分化检测试剂,成脂诱导培养基为含有0.2mmoL/L谷氨酰胺、1μg/mLIGF-2、2mmol/L 3-磷酸甘油、0.25mmoL/L倍氯米松、0.1mmoL/L异丁基甲基黄嘌呤、100μmoL/L吲哚美辛、1μmoL/L乙酰CoA、体积分数2%胎牛血清的AMEM培养基;
所述成骨分化诱导及检测试剂套装:包括100mL成骨诱导培养基和10mL成骨分化检测试剂,成骨诱导培养基为含有0.5mmoL/L谷氨酰胺、0.5mmoL/L倍氯米松、5μg/mL TGF-β、2mmol/Lβ-甘油磷酸钠、15mmol/L维生素D3、20mmol/L维生素C、体积分数2%胎牛血的AMEM培养基;
所述成软骨分化诱导及检测试剂套装:包括100mL成软骨诱导培养基和10mL成软骨分化检测试剂,软骨诱导培养基为含有5ng/ml TGF-β1、20mg/L维生素C、10nmol/L倍他米松、50mg/ml ITS、10mmol/L氨基葡萄糖、1mmol/L丙酮酸钠、2ug/mg亚油酸、1ng/ml人血清白蛋白、10mmol/Lβ-甘油磷酸钠、体积分数2%胎牛血清的AMEM培养基。
操作步骤如下:
(1)流式检测步骤:
将细胞悬液按照每管1×105数量分装到EP管内,离心后加入1mL PBS重悬后离心;
加入相应的流式抗体,室温避光孵育30min;
每管加入1mL PBS重悬后离心;
每管加入1mL PBS重悬后流式细胞仪检测。检测结果符合脂肪间充质干细胞表型。IgG1为同型对照,检测结果CD73、CD90、CD105、CD49d为阳性表达,CD34、CD45、CD106为阴性表达。
(2)成脂分化诱导及检测步骤:
准备6孔培养板,将P4细胞按照2×103个/平方厘米的规格接种于普通培养液中;
待细胞融合度长至70-80%,更换成脂诱导培养基培养,每三天换液一次。
18天后去除全部培养液,使用PBS清洗两次。
4%多聚甲醛室温固定20分钟;PBS清洗3次;
按照1ml/孔加入成脂分化检测试剂,室温孵育一小时;
清除掉没有完全结合的染料,75%乙醇溶液清洗3次;
倒置显微镜观察拍照记录。检测结果出现红色液滴。
(3)成骨分化诱导及检测步骤:
准备6孔培养板,将P4细胞按照5×103个/平方厘米的规格接种于普通培养液中;
待细胞融合度长至40-50%,更换成骨诱导培养基;每三天换液一次;
18天后去除全部培养液,使用PBS清洗两次;
使用4%多聚甲醛室温固定15min,完成后使用PBS冲洗两次;
按照1ml/孔加入成骨分化检测试剂,室温孵育20min并轻微振荡;
清除掉没有完全结合的染料,用PBS漂洗并振荡5min重复4次;
倒置显微镜观察拍照记录。检测结果出现红色结节。
(4)成软骨分化诱导及检测步骤:
准备6孔培养板,将P4细胞按照5×103个/平方厘米的规格接种于普通培养液中;
待细胞融合度长至50-60%,更换成软骨诱导培养基;每三天换液一次;
13天后去除全部培养液,使用PBS清洗两次;
用细胞固定液固定30min,再用3%醋酸水溶液洗2次后;
按照1ml/孔加入成软骨分化检测试剂染色10min;
清除掉没有完全结合的染料,3%醋酸水溶液洗3次;
倒置显微镜观察拍照记录。检测结果出现蓝色。
本发明提高诱导分化效率,缩短诱导分化的时间,传统成骨、成脂诱导分化通常需要大约24天,时间较长且诱导效率较低,本发明将成骨、成脂诱导分化时间缩短至18天,同时传统流式检测大多只针对间充质干细胞通用的表面标志,而脂肪间充质干细胞具有不同于其他来源间充质干细胞的阳性表达的表面标志CD49d和阴性表达的CD106,本发明试剂盒中增加了CD49d抗体和CD106抗体,从而得出更为准确的鉴定结果。
综上所述,本发明的内容并不局限在上述的实施例中,相同领域内的有识之士可以在本发明的技术指导思想之内可以轻易提出其他的实施例,但这种实施例都包括在本发明的范围之内。
Claims (6)
1.一种用于鉴定脂肪间充质干细胞的试剂盒,其特征在于,包括流式表型检测试剂套装、细胞固定液、普通培养基、成脂分化诱导及检测试剂套装、成骨分化诱导及检测试剂套装、成软骨分化诱导及检测试剂套装;
所述流式表型检测试剂套装:包括CD73抗体、CD90抗体、CD105抗体、CD34抗体、CD45抗体、CD49d抗体、CD106抗体、IgG1抗体,每只均为200uL;
所述成脂分化诱导及检测试剂套装:包括100mL成脂诱导培养基和10mL成脂分化检测试剂,成脂诱导培养基为含有0.2-2mmoL/L谷氨酰胺、1-20μg/mL IGF-2、2-5mmol/L 3-磷酸甘油、0.25-1mmoL/L倍氯米松、0.1-0.5mmoL/L异丁基甲基黄嘌呤、100-200μmoL/L吲哚美辛、1-50μmoL/L乙酰CoA、体积分数2-10%胎牛血清的AMEM培养基;
所述成骨分化诱导及检测试剂套装:包括100mL成骨诱导培养基和10mL成骨分化检测试剂,成骨诱导培养基为含有0.5-2mmoL/L谷氨酰胺、0.5-2mmoL/L倍氯米松、5-20μg/mL TGF-β、2-10mmol/Lβ-甘油磷酸钠、15-25mmol/L维生素D3、20-30mmol/L维生素C、体积分数2-10%胎牛血的AMEM培养基;
所述成软骨分化诱导及检测试剂套装:包括100mL成软骨诱导培养基和10mL成软骨分化检测试剂,成软骨诱导培养基为含有5-10ng/ml TGF-β1、20-50mg/L维生素C、10-20nmol/L倍他米松、50-100mg/ml ITS、10-60mmol/L氨基葡萄糖、1-20mmol/L丙酮酸钠、2-10ug/mg亚油酸、1-8ng/ml人血清白蛋白、10-20mmol/Lβ-甘油磷酸钠、体积分数2-10%胎牛血清的AMEM培养基。
2.根据权利要求1所述的用于鉴定脂肪间充质干细胞的试剂盒,其特征在于,所述细胞固定液为20mL质量百分比浓度4%多聚甲醛的水溶液。
3.根据权利要求1所述的用于鉴定脂肪间充质干细胞的试剂盒,其特征在于,所述普通培养基为20mL含体积分数2-8%胎牛血清的AMEM培养基。
4.根据权利要求1所述的用于鉴定脂肪间充质干细胞的试剂盒,其特征在于,所述成脂分化检测试剂为含有1g/L茜素磺酸钠水溶液。
5.根据权利要求1所述的用于鉴定脂肪间充质干细胞的试剂盒,其特征在于,所述成骨分化检测试剂为含有质量体积分数为0.5%油红O的异丙醇溶液。
6.根据权利要求1所述的用于鉴定脂肪间充质干细胞的试剂盒,其特征在于,所述成软骨分化检测试剂为含有10g/L阿尔新兰、质量体积分数3%醋酸的水溶液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610312843.4A CN105866431B (zh) | 2016-05-11 | 2016-05-11 | 用于鉴定脂肪间充质干细胞的试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610312843.4A CN105866431B (zh) | 2016-05-11 | 2016-05-11 | 用于鉴定脂肪间充质干细胞的试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105866431A true CN105866431A (zh) | 2016-08-17 |
CN105866431B CN105866431B (zh) | 2018-01-23 |
Family
ID=56631630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610312843.4A Active CN105866431B (zh) | 2016-05-11 | 2016-05-11 | 用于鉴定脂肪间充质干细胞的试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105866431B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110819587A (zh) * | 2019-11-27 | 2020-02-21 | 山东省齐鲁细胞治疗工程技术有限公司 | 一种间充质干细胞无支架三维凝胶干性鉴定方法 |
CN111826343A (zh) * | 2020-07-23 | 2020-10-27 | 北京中卫医正科技有限公司 | 一种增强诱导软骨分化的细胞培养液、方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101984048A (zh) * | 2010-11-24 | 2011-03-09 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种培养间充质干细胞的培养基 |
CN102803476A (zh) * | 2009-09-14 | 2012-11-28 | 程临钊 | 血细胞重编程产生多潜能干细胞和多功能干细胞 |
CN103087977A (zh) * | 2013-01-25 | 2013-05-08 | 协和干细胞基因工程有限公司 | 一种体外高效扩增动物细胞的培养液及其用途 |
CN104357383A (zh) * | 2014-10-11 | 2015-02-18 | 张炳强 | 人脂肪间充质干细胞制备方法及其在制备疾病药物的应用 |
-
2016
- 2016-05-11 CN CN201610312843.4A patent/CN105866431B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102803476A (zh) * | 2009-09-14 | 2012-11-28 | 程临钊 | 血细胞重编程产生多潜能干细胞和多功能干细胞 |
CN101984048A (zh) * | 2010-11-24 | 2011-03-09 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 一种培养间充质干细胞的培养基 |
CN103087977A (zh) * | 2013-01-25 | 2013-05-08 | 协和干细胞基因工程有限公司 | 一种体外高效扩增动物细胞的培养液及其用途 |
CN104357383A (zh) * | 2014-10-11 | 2015-02-18 | 张炳强 | 人脂肪间充质干细胞制备方法及其在制备疾病药物的应用 |
Non-Patent Citations (3)
Title |
---|
刑昕等: "体外分离培养人源性脂肪间充质干细胞及其鉴定", 《中国输血杂志》 * |
毕晓娟等: "大鼠腹股沟脂肪间充质干细胞的分离、培养、鉴定及活体标记", 《中国组织工程研究与临床康复》 * |
郭常敏等: "人脂肪间充质干细胞体外培养鉴定与诱导分化的初步研究", 《遵义医学院学报》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110819587A (zh) * | 2019-11-27 | 2020-02-21 | 山东省齐鲁细胞治疗工程技术有限公司 | 一种间充质干细胞无支架三维凝胶干性鉴定方法 |
CN111826343A (zh) * | 2020-07-23 | 2020-10-27 | 北京中卫医正科技有限公司 | 一种增强诱导软骨分化的细胞培养液、方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105866431B (zh) | 2018-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mushahary et al. | Isolation, cultivation, and characterization of human mesenchymal stem cells | |
Ramkisoensing et al. | Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts | |
Aldridge et al. | Assay validation for the assessment of adipogenesis of multipotential stromal cells—a direct comparison of four different methods | |
Mareschi et al. | Multipotent mesenchymal stromal stem cell expansion by plating whole bone marrow at a low cellular density: a more advantageous method for clinical use | |
Bakopoulou et al. | Comparative characterization of STRO-1neg/CD146pos and STRO-1pos/CD146pos apical papilla stem cells enriched with flow cytometry | |
CN106350483A (zh) | 诱导脂肪间充质干细胞向软骨细胞分化的培养方法 | |
CN105331580B (zh) | 增强间充质干细胞趋化能力和趋化因子ccl5表达方法 | |
Suszynska et al. | The proper criteria for identification and sorting of very small embryonic-like stem cells, and some nomenclature issues | |
CN102288471A (zh) | 一种悬浮细胞的免疫荧光染色方法 | |
CN102757936A (zh) | 人脂肪干细胞增殖促进剂及其应用方法 | |
CN105866431A (zh) | 用于鉴定脂肪间充质干细胞的试剂盒 | |
TWI523947B (zh) | 人類多能性類胚胎幹細胞先驅細胞 | |
CN106754637A (zh) | 一种经血源性子宫内膜干细胞的分离提取方法 | |
Machado et al. | The dental pulp stem cell niche based on aldehyde dehydrogenase 1 expression | |
Hynes et al. | Differentiation of iPSC to mesenchymal stem-like cells and their characterization | |
CN105866432B (zh) | 用于鉴定牙髓间充质干细胞的试剂盒 | |
Brandau et al. | Orbital fibroblasts from Graves' orbitopathy patients share functional and immunophenotypic properties with mesenchymal stem/stromal cells | |
Didilescu et al. | Dental pulp as a stem cell reservoir | |
CN106047804A (zh) | 一种脂肪干细胞的纯化方法及干细胞在成骨诱导及成软骨诱导上的应用 | |
Crisan | Transition of mesenchymal stem/stromal cells to endothelial cells | |
Lee et al. | Comparison of ganglioside expression between human adipose-and dental pulp-derived stem cell differentiation into osteoblasts | |
CN105891512A (zh) | 用于鉴定脐带间充质干细胞的试剂盒 | |
JP2018533926A (ja) | 脂肪間質細胞を急速分離する組成物 | |
Szepesi et al. | ABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cells | |
Bagheri‐Hosseinabadi et al. | Combination of 5‐azaytidine and hanging drop culture convert fat cell into cardiac cell |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171221 Address after: 300403 Zhongguancun (Tianjin) trusted industrial park, Beichen District, Tianjin City, Tianjin Applicant after: Tianjin Xin Purcell Biological Medicine Technology Co Ltd Address before: 300392 Tianjin city Nankai District Binhai New District Huayuan Industrial Park (outer ring) two Haitai Development Road No. four Building No. 4 402A Applicant before: TIANJIN PURI PURCELL BIOTECHNOLOGY CO., LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |